Counterfeit and grey market protection in the pharmaceutical market–
security for patients and original manufacturers
security for patients and original manufacturers
Product protection for pharmaceuticals
According to most recent estimates, 6 to 10% of pharmaceutical products sold on the global market are counterfeited – with an increasing trend. Particularly affected: high-value medications and so-called lifestyle drugs.
In the fight against fraudulent assaults on patient safety and original manufacturers’ financial interests, tesa scribos has developed effective protection systems for both, the doubtless
authentication of original products as well as the traceability and
prevention of grey market trade.
tesa Holospot® on pharmaceuticals
tesa Holospot® –
counterfeit protection and product tracing through individual information on the product
The tesa Holospot® technology equips each individual product of yours with a counterfeit-proof data carrier label for authentication and a comprehensive traceability. tesa Holospot® can be easily applied to the secondary or primary packaging alike, e.g. on cardboard boxes, blisters, vials or ampules.
So that even patients can have solid proof of authenticity.
Further information on the topic:
Effective brand protection in mass markets >>
Manipulation and theft protection >>
Flexible solutions in print >>
Contact us